Tue, 08/26/2025 - 16:20 Gizmodo In new Phase III trial data released Tuesday, people taking orforglipron lost substantially more weight than people taking a placebo. Tags Health, GLP-1s, obesity, Ozempic, pharmaceuticals Source A Pill to Fight Obesity Is on the Verge of Approval